T1	Gene_or_protein	20 25	HSP90
T2	Chemical	17 42	of HSP90 Inhibitor AUY922
T3	Chemical	47 56	Erlotinib
T4	Disease	61 90	EGFR -Mutant Lung Cancer With
T5	Pharmacodynamic_phenotype	91 175	Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors .
R1	decreases	Arg1:T1	Arg2:T2
R2	influences	Arg1:T1	Arg2:T3
R3	treats	Arg1:T1	Arg2:T4
R4	treats	Arg1:T1	Arg2:T5
R5	decreases	Arg1:T2	Arg2:T1
R6	influences	Arg1:T2	Arg2:T3
R7	treats	Arg1:T2	Arg2:T4
R8	treats	Arg1:T2	Arg2:T5
R9	influences	Arg1:T3	Arg2:T2
R10	treats	Arg1:T3	Arg2:T4
R11	treats	Arg1:T3	Arg2:T5
R12	isAssociatedWith	Arg1:T4	Arg2:T1
R13	isAssociatedWith	Arg1:T4	Arg2:T2
R14	isAssociatedWith	Arg1:T4	Arg2:T3
R15	isAssociatedWith	Arg1:T4	Arg2:T5
R16	isAssociatedWith	Arg1:T5	Arg2:T1
R17	isAssociatedWith	Arg1:T5	Arg2:T2
R18	isAssociatedWith	Arg1:T5	Arg2:T3
R19	treats	Arg1:T5	Arg2:T4
